UroGen Pharma Ltd (URGN) — Strategic Asset Allocation Index
UroGen Pharma Ltd (URGN) has a Strategic Asset Allocation Index of 18.2% as of September 2024. Strategic assets (PP&E of $- plus long-term investments of $4.64 Million) total $4.64 Million, measured against net assets of $25.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
UroGen Pharma Ltd Strategic Asset Allocation Index (2013–2021)
This chart shows how UroGen Pharma Ltd's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of September 2024, the index stands at 18.2%, representing strategic assets of $4.64 Million against net assets of $25.52 Million USD. Explore cash flow conversion of UroGen Pharma Ltd to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for UroGen Pharma Ltd (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for UroGen Pharma Ltd from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see UroGen Pharma Ltd stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 31.4% | $2.64 Million | $1.97 Million | $675.00K | $8.41 Million | ▲ +25.1 pp |
| 2020 | 6.3% | $6.10 Million | $4.20 Million | $1.89 Million | $96.36 Million | ▼ -23.2 pp |
| 2019 | 29.5% | $53.27 Million | $4.71 Million | $48.55 Million | $180.30 Million | ▲ +28.5 pp |
| 2018 | 1.1% | $948.00K | $948.00K | $- | $90.09 Million | ▼ -0.1 pp |
| 2017 | 1.2% | $805.00K | $805.00K | $- | $68.52 Million | ▼ -3.4 pp |
| 2016 | 4.5% | $741.00K | $741.00K | $- | $16.31 Million | ▲ +3.0 pp |
| 2015 | 1.5% | $259.00K | $259.00K | $- | $17.15 Million | ▼ -0.5 pp |
| 2014 | 2.0% | $71.00K | $71.00K | $- | $3.47 Million | ▼ -0.8 pp |
| 2013 | 2.8% | $77.00K | $77.00K | $- | $2.74 Million | — |